Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H17NO9S2 |
Molecular Weight | 491.491 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC2=C1NC(=O)C2(C3=CC=C(OS(O)(=O)=O)C=C3)C4=CC=C(OS(O)(=O)=O)C=C4
InChI
InChIKey=URNFTLVCQLRCMN-UHFFFAOYSA-N
InChI=1S/C21H17NO9S2/c1-13-3-2-4-18-19(13)22-20(23)21(18,14-5-9-16(10-6-14)30-32(24,25)26)15-7-11-17(12-8-15)31-33(27,28)29/h2-12H,1H3,(H,22,23)(H,24,25,26)(H,27,28,29)
Molecular Formula | C21H17NO9S2 |
Molecular Weight | 491.491 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulisatin (also known as DAN-603) is an indolinone derivative patented by Andreu, Dr., S. A. as a laxative. In preclinical models, Sulisatin increases selectively the colon motility without modifying the speed of gastric, intestinal (small intestine) and caecal emptying in rats. Sulisatin is unable to inhibit water absorption in rat colon while small amounts of Sulisatin may inhibit it significantly.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/583222
rat 1.5, 3 and 6 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:20:51 GMT 2023
by
admin
on
Fri Dec 15 17:20:51 GMT 2023
|
Record UNII |
5EOG8KQT0Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29697
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3885
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
C012120
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
5EOG8KQT0Y
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
SUB10745MIG
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
2535
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
C74275
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
m947
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
54935-03-4
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
100000083768
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
41238
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
DTXSID80203451
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104944
Created by
admin on Fri Dec 15 17:20:51 GMT 2023 , Edited by admin on Fri Dec 15 17:20:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |